Ximino
NDC Package 10631-331-69
Package Information
Ximino is a medication used to treat moderate to severe acne in people 12 years and older. Marketed by Sun Pharmaceutical Industries, Inc, this product is identified by NDC 10631-331 and is authorized under FDA application NDA201922.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 10631 - Sun Pharmaceutical Industries, Inc
- 10631-331 - Ximino
- 10631-331-69 - 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK
- 10631-331 - Ximino
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (10631-331). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 10631-331-69 identifies a specific commercial package of 10 capsule, extended release in 1 blister pack of Ximino, labeled by Sun Pharmaceutical Industries, Inc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc on October 25, 2017. The current certification is valid through August 31, 2022.
What are the primary indications for this medication?
This medication is used to treat moderate to severe acne in people 12 years and older. It helps to reduce the number of pimples. Minocycline belongs to a class of drugs known as tetracycline antibiotics. It works by stopping the growth of bacteria that may make acne worse. This antibiotic treats acne that is thought to be caused by a bacterial infection. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.
How is this Sun Pharmaceutical Industries, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 10631033169. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.